May 13, 2024
6 min read
UBC Perspectives from Asembia’s AXS24 Summit
Patient services are undergoing rapid changes based on regulatory requirements and evolving patient and prescriber expectations.
UBC Insights
Insights from
UBC's Expert Voices
Featured Updates
Blog
October 30, 2025
6 min read
Drug Repurposing in Rare Diseases: The Impact of Natural History Studies
Drug repurposing is transforming the landscape of rare disease treatment by leveraging existing medications for new uses. With significantly lower development costs and faster timelines, this approach is gaining traction—especially when supported by natural history studies that provide deep insights into disease progression and real-world treatment patterns.
Blog
October 23, 2025
6 min read
EMA Issues Guidance on Risk Minimisation Measures for Medicinal Products with Embryo-Foetal Risks
The EMA’s August 2025 guidance on embryo-foetal risk minimisation marks a pivotal step in harmonizing safety protocols across the EU. This blog breaks down the new Addendum I to GVP Module XVI, clarifying what constitutes a Pregnancy Prevention Programme and how risk minimisation tools can be effectively implemented without compromising patient access to essential treatments.
Blog
October 20, 2025
9 min read
To Rescue or Not to Rescue Your Study: How to Spot Trigger Points in Strategic Partnerships
Instability is woven into our industry’s DNA. We operate daily in a high-stakes, high-risk environment where financial pressures, regulatory changes, and patient lives hang in the balance. The CRO selection process reflects this tension, few other sectors require competitors to both challenge and collaborate with one another, often for the same client. Our ecosystem is […]
Posts by Date
Blog
Blog
April 29, 2024
5 min read
The Use of AI/ChatGPT in the Preparation of Aggregate Safety Reports & Signal Management Activities
At UBC, we share a vision where AI and safety writing come together to forge a safer path.
Blog
April 19, 2024
3 min read
Experience the Difference with UBC’s REMS Professionals
At UBC, we are committed to our continued partnership with our customers and to providing exceptional work on behalf of our patients
Blog
April 12, 2024
5 min read
EDC and PV Safety Database Integration: Practical Application and Implementation
Our PV experts discuss best practices and considerations for implementation involving PV technical, clinical, and operational stakeholders to ensure seamless compatibility.
Blog
April 1, 2024
6 min read
Enhancing Patient Engagement: Insights from Access USA 2024
Read about three key areas where patient service providers are focusing to better service patients' needs with advocates and biopharma.
Blog
March 15, 2024
4 min read
Achieving Global Harmonization: PV & RMP Regulatory Compliance
UBC Pharmacovigilance experts, Helena Pedrosa and Philippe Botteron presented at DIA Europe on how to achieve global harmonization of PV & RMP regulatory compliance.
Blog
March 12, 2024
4 min read
UBC Participates in Rare Disease Day® at NIH 2024
UBC joined patients, researchers, and industry leaders at this year’s Rare Disease Day at NIH to discuss advancing research, improving diagnostics, and accelerating treatments for those living with rare diseases.
Blog
March 4, 2024
4 min read
The Joint Clinical Assessment Affect on European Patient Access
Find out what the new Joint Clinical Assessment from the European Union could mean for accelerating patient access to innovative medicines.
Blog
February 19, 2024
7 min read
Pharmacovigilance AI Best Practices: How to Apply the EU AI Act 2023
Read into the latest PV AI Best Practices, discover how to apply the EU AI Act 2023.
Previous
